Pneumococci causing invasive disease in children prior to the introduction of pneumococcal conjugate vaccine in Scotland

被引:7
|
作者
Clarke, Stuart C.
Jefferies, Johanna M. C.
Smith, Andrew J.
McMenamin, Jim
Mitchell, Timothy J.
Edwards, Giles F. S.
机构
[1] Stobhill Gen Hosp, Scottish Meningococcus & Pneumococcus Reference L, Glasgow G21 3UW, Lanark, Scotland
[2] Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland
[3] Portsmouth City Teaching PCT, Portsmouth PO3 6DP, Hants, England
[4] Glasgow Dent Hosp & Sch, Glasgow G2 3JZ, Lanark, Scotland
[5] Hlth Protect Scotland, Glasgow G3 7LN, Lanark, Scotland
关键词
D O I
10.1099/jmm.0.46550-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study aimed to determine the serotypes and sequence types (STs) of pneumococci causing paediatric invasive disease in Scotland prior to the introduction of pneumococcal conjugate vaccines (PCVs). All invasive pneumococci isolated between 2000 and 2004 from children aged less than 5 years in Scotland were used. The isolates were characterized by serotyping and multi-locus sequence typing. Two hundred and seventeen pneumococci were characterized into 22 different serogroups/types, the most common, in rank order, being 14, 19F, 6B, 18C, 23F, 9V, 4, 1, 19A and 6A. They were further genotyped into 77 different STs, the three most common being 9, 162 and 176. Common serotypes possessed multiple STs, but pneumococci of a particular clone were mostly associated with a particular serotype. The seven most common serotypes are included in the 7-valent polysaccharide conjugate vaccine (PCV7). Serotype coverage for PCV7 was 76.5 % in those aged less than 5 years but increased to 88.9 % for those aged 1 year. The introduction of PCV7 into the childhood immunization schedule would reduce the burden of pneumococcal disease in children, although continued surveillance of invasive pneumococcal disease will be required before, during and after the introduction of PCVs.
引用
收藏
页码:1079 / 1084
页数:6
相关论文
共 50 条
  • [31] Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003-2008
    Moodley, Krishnee
    Coovadia, Yacoob Mahomed
    Cohen, Cheryl
    Meiring, Susan
    Lengana, Sarona
    De Gouveia, Linda
    von Mollendorf, Claire
    Crowther-Gibson, Penny
    Quan, Vanessa
    Eley, Brian
    Reubenson, Gary
    Nana, Trusha
    von Gottberg, Anne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (04) : 424 - 430
  • [33] Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
    Whitney, CG
    Farley, MM
    Hadler, J
    Harrison, LH
    Bennett, NM
    Lynfield, R
    Reingold, A
    Cieslak, PR
    Pilishvili, T
    Jackson, D
    Facklam, RR
    Jorgensen, JH
    Schuchat, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18): : 1737 - 1746
  • [34] Serotypes of Streptococcus pneumoniae Isolates from Children with Invasive Pneumococcal Disease in Turkey: Baseline Evaluation of the Introduction of the Pneumococcal Conjugate Vaccine Nationwide
    Ceyhan, Mehmet
    Gurler, Nezahat
    Yaman, Akgun
    Ozturk, Candan
    Oksuz, Lutfiye
    Ozkan, Sengul
    Keser, Melike
    Salman, Nuran
    Alhan, Emre
    Esel, Duygu
    Gultekin, Meral
    Camcioglu, Yildiz
    Gul, Mustafa
    Sorguc, Yelda
    Aydemir, Sohret
    Gunaydin, Murat
    Yakupogullari, Yusuf
    Kizirgil, Ahmet
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (06) : 1028 - 1030
  • [35] THE EFFECTIVENESS OF THE PNEUMOCOCCAL CONJUGATE VACCINE IN CHILDREN WITH SICKLE CELL DISEASE: A NATIONAL STUDY OF HOSPITALIZATION FOR INVASIVE PNEUMOCOCCAL DISEASE
    McCavit, Timothy
    Xuan, Lei
    Zhang, Song
    Flores, Glenn
    Quinn, Charles
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 789 - 790
  • [36] Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine
    Halasa, Natasha B.
    Shankar, Sadhna M.
    Talbot, Thomas R.
    Arbogast, Patrick G.
    Mitchel, Ed F.
    Wang, Winfred C.
    Schaffner, William
    Craig, Allen S.
    Griffin, Marie R.
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (11) : 1428 - 1433
  • [37] Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine
    Kaplan, Sheldon L.
    Barson, William J.
    Lin, Philana Ling
    Romero, Jose R.
    Bradley, John S.
    Tan, Tina Q.
    Hoffman, Jill A.
    Givner, Laurence B.
    Mason, Edward O., Jr.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (03) : 203 - 207
  • [38] Antimicrobial Resistance among Isolates Causing Invasive Pneumococcal Disease before and after Licensure of Heptavalent Conjugate Pneumococcal Vaccine
    Karnezis, Tom Theodore
    Smith, Ann
    Whittier, Susan
    Haddad, Joseph, Jr.
    Saiman, Lisa
    PLOS ONE, 2009, 4 (06):
  • [39] Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010
    Thoon, Koh Cheng
    Chong, Chia Yin
    Tee, Nancy Wen Sim
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (03) : E209 - E215
  • [40] Invasive pneumococcal disease among children in a health district of Barcelona:: early impact of pneumococcal conjugate vaccine
    Calbo, E.
    Diaz, A.
    Canadell, E.
    Fabrega, J.
    Uriz, S.
    Xercavins, M.
    Morera, M. A.
    Cuchi, E.
    Rodriguez-Carballeira, M.
    Garau, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (09) : 867 - 872